Global Prevalence and Major Risk Factors of Diabetic Retinopathy

OBJECTIVE To examine the global prevalence and major risk factors for diabetic retinopathy (DR) and vision-threatening diabetic retinopathy (VTDR) among people with diabetes. RESEARCH DESIGN AND METHODS A pooled analysis using individual participant data from population-based studies around the world was performed. A systematic literature review was conducted to identify all population-based studies in general populations or individuals with diabetes who had ascertained DR from retinal photographs. Studies provided data for DR end points, including any DR, proliferative DR, diabetic macular edema, and VTDR, and also major systemic risk factors. Pooled prevalence estimates were directly age-standardized to the 2010 World Diabetes Population aged 20–79 years. RESULTS A total of 35 studies (1980–2008) provided data from 22,896 individuals with diabetes. The overall prevalence was 34.6% (95% CI 34.5–34.8) for any DR, 6.96% (6.87–7.04) for proliferative DR, 6.81% (6.74–6.89) for diabetic macular edema, and 10.2% (10.1–10.3) for VTDR. All DR prevalence end points increased with diabetes duration, hemoglobin A1c, and blood pressure levels and were higher in people with type 1 compared with type 2 diabetes. CONCLUSIONS There are approximately 93 million people with DR, 17 million with proliferative DR, 21 million with diabetic macular edema, and 28 million with VTDR worldwide. Longer diabetes duration and poorer glycemic and blood pressure control are strongly associated with DR. These data highlight the substantial worldwide public health burden of DR and the importance of modifiable risk factors in its occurrence. This study is limited by data pooled from studies at different time points, with different methodologies and population characteristics.

[1]  H. Taylor,et al.  Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project , 2000, The British journal of ophthalmology.

[2]  Ann L. Albright,et al.  Prevalence of diabetic retinopathy in the United States, 2005-2008. , 2010, JAMA.

[3]  V. Mohan,et al.  Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I. , 2005, Investigative ophthalmology & visual science.

[4]  R. Hamman,et al.  Prevalence and Risk Factors of Diabetic Retinopathy in Non-Hispanic Whites and Hispanics With NIDDM: San Luis Valley Diabetes Study , 1989, Diabetes.

[5]  Nathan Congdon,et al.  The Prevalence of Diabetic Retinopathy in the United States , 2002 .

[6]  J. J. Wang,et al.  Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study. , 1998, Ophthalmology.

[7]  R. Klein,et al.  Rates of Progression in Diabetic Retinopathy During Different Time Periods , 2009, Diabetes Care.

[8]  D L DeMets,et al.  Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. , 1988, JAMA.

[9]  N. Keyfitz.  3. Sampling variance of standardized mortality rates. , 1966, Human biology.

[10]  R. Klein,et al.  Is the Risk of Diabetic Retinopathy Greater in Non-Hispanic Blacks and Mexican Americans Than in Non-Hispanic Whites With Type 2 Diabetes?: A U.S. population study , 1998, Diabetes Care.

[11]  R. Klein,et al.  Diabetic Retinopathy in Mexican Americans and Non-Hispanic Whites , 1988, Diabetes.

[12]  Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes : a randomised placebo-controlled trial , 2022 .

[13]  John H Fuller,et al.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial , 2004, The Lancet.

[14]  M. C. Leske,et al.  The prevalence of diabetic retinopathy among adults in the United States. , 2004, Archives of ophthalmology.

[15]  Beverley Balkau,et al.  The prevalence of and factors associated with diabetic retinopathy in the Australian population. , 2003, Diabetes care.

[16]  R. Klein,et al.  The Role of Genetics in Susceptibility to Diabetic Retinopathy , 2009, International ophthalmology clinics.

[17]  D L DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. , 1984, Ophthalmology.

[18]  M. Roy.  Diabetic retinopathy in African Americans with type 1 diabetes: The New Jersey 725: II. Risk factors. , 2000, Archives of ophthalmology.

[19]  S. Hayreh,et al.  Ischemic Optic Neuropathy , 2004, Albert and Jakobiec's Principles and Practice of Ophthalmology.

[20]  R. Klein,et al.  Diabetic retinopathy in a multi-ethnic cohort in the United States. , 2006, American journal of ophthalmology.

[21]  Tin Aung,et al.  Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. , 2008, Ophthalmology.

[22]  R. Klein,et al.  The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. , 1992, Ophthalmology.

[23]  P. Mitchell,et al.  Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial , 2007, The Lancet.

[24]  R. Klein,et al.  Is there an ethnic difference in the effect of risk factors for diabetic retinopathy? , 1993, Annals of epidemiology.

[25]  Ronald Klein,et al.  The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. , 2004, Archives of ophthalmology.

[26]  K. Dou,et al.  Prevalence of diabetes among men and women in China. , 2010, The New England journal of medicine.

[27]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[28]  B. Munoz,et al.  Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. , 2001, Diabetes care.

[29]  R. Klein,et al.  Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. , 2004, Ophthalmology.

[30]  Sarah Parish,et al.  MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.

[31]  B. Klein,et al.  Overview of epidemiologic studies of diabetic retinopathy. , 2007, Ophthalmic epidemiology.

[32]  Wenying Yang,et al.  Prevalence of diabetes among men and women in China. , 2010, The New England journal of medicine.

[33]  J. Shaw,et al.  Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.

[34]  D L DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. , 1984, Archives of ophthalmology.

[35]  D. Friedman,et al.  Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. , 2009, Ophthalmology.

[36]  S. Schinner.  Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes , 2009 .

[37]  M. Roy.  Diabetic retinopathy in African Americans with type 1 diabetes: The New Jersey 725: II. Risk factors. , 2000, Archives of ophthalmology.

[38]  D. DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.

[39]  E. Harris,et al.  Racial Differences in the Relationship Between Blood Pressure and Risk of Retinopathy Among Individuals With NIDDM , 1993, Diabetes Care.

[40]  S. Colagiuri,et al.  The Diabetes Control and Complications Trial , 1983, Henry Ford Hospital medical journal.

[41]  Diederick Grobbee,et al.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. , 2008, The New England journal of medicine.